Search results
Results From The WOW.Com Content Network
still/moving image of internal parts of heart. A transthoracic echocardiogram (TTE) is the most common type of echocardiogram, which is a still or moving image of the internal parts of the heart using ultrasound. In this case, the probe (or ultrasonic transducer) is placed on the chest or abdomen of the subject to get various views of the heart.
Patients on the blood-thinning drug Warfarin experienced higher rates of dementia and Alzheimer's, according to a new study. Widely-used heart drug linked to increased dementia risk Skip to main ...
The sternum is a narrow, flat bone, forming the middle portion of the front of the chest. The top of the sternum supports the clavicles (collarbones) and its edges join with the costal cartilages of the first two pairs of ribs. The inner surface of the sternum is also the attachment of the sternopericardial ligaments. [ 2 ]
Mayo Clinic, Rochester, was ranked in the top 10 in all but one of 16 specialties, in the top 4 in 13 specialties, and was the #1 ranked hospital in 8 of the 12 data-driven specialties. This year U.S. News expanded their common procedures and conditions list to 9 individual measures, and Mayo was one of fewer than 70 hospitals to score High ...
In fact, people living with type 2 diabetes, stroke or heart disease who ate the most anti-inflammatory foods “developed dementia 2 years later than those with cardiometabolic diseases and a pro ...
After 670 days, there were 1,172 new diagnoses of dementia among the study participants. When compared with people who took DPP-4 inhibitors, those who took SGLT-2 inhibitors had a 35 percent ...
An artificial cardiac pacemaker, commonly referred to as simply a pacemaker, is an implanted medical device that generates electrical pulses delivered by electrodes to one or more of the chambers of the heart. Each pulse causes the targeted chamber (s) to contract and pump blood, [3] thus regulating the function of the electrical conduction ...
The results of a new large-scale study published in The BMJ suggest that a relatively new diabetes drug might reduce the risk of developing dementia in people with type 2 diabetes. Taking SGLT-2 ...